• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP TOTAL HCG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP TOTAL HCG Back to Search Results
Model Number N/A
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/11/2020
Event Type  malfunction  
Manufacturer Narrative
Customer reports a single non-reproducible discordant patient result on advia centaur total hcg (thcg) reagent lot 029312.The initial thcg result when the sample was initially tested was positive for pregnancy.The result was questioned by the physician and the same sample was repeated and resulted negative for pregnancy.Advia centaur thcg reagent lot 029312 calibration and qc results were acceptable.Service was sent and a total service check was performed, no instrument issues were identified.Advia centaur thcg precision was evaluated post service, 3 negative patient samples and 2 levels of controls in replicates of 5 were run.The advia centaur thcg precision was found to be acceptable.The customer reports that post service the advia centaur thcg assay is performing within specification.Siemens cannot definitively determine the cause of this discrepant result.Contributing factors such as pre-analytical variables cannot be ruled out.Pre-analytic variables can affect the quality of the sample, and deviation from recommended best practices can lead to erroneous results.Quality control was in range and no issues were noted with other patient samples indicating that the instrument and reagents were performing acceptably.Repeat of the same sample yielded expected results.Based on the results of the investigation, return of the patient sample is not warranted.A product issue has not been identified.The instructions for use states in the interpretation of results section: "interpretation of results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings." the limitations section states: "all in vitro assays can generate erroneous results, both clinically false positive results (test results suggesting a condition that is absent) and clinically false negative results (test results failing to identify a condition that is present).".
 
Event Description
Customer obtained an elevated advia centaur xp total hcg (thcg) result that was questioned by the physician.The sample was repeated on the advia centaur xp thcg assay and resulted lower.There are no reports that treatment was altered or prescribed or adverse health consequences due to the elevated advia centaur xp thcg result.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR XP TOTAL HCG
Type of Device
TOTAL HCG
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown, ny
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
333 coney street
east walpole, ma
Manufacturer Contact
louise mclaughlin
333 coney street
east walpole, ma 
6604381
MDR Report Key10252027
MDR Text Key218990948
Report Number1219913-2020-00168
Device Sequence Number1
Product Code JHI
UDI-Device Identifier00630414505176
UDI-Public00630414505176
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K925277
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 07/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/14/2020
Device Model NumberN/A
Device Catalogue Number10308985
Device Lot Number029312
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/15/2020
Initial Date FDA Received07/09/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/14/2019
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-